Cargando…
A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis
Tirasemtiv is a fast skeletal troponin activator that sensitizes the sarcomere to calcium and increases muscle force following subtetanic nerve input. In an animal model of myasthenia gravis (MG), single oral doses of tirasemtiv improved muscle force and reduced fatigability. The purpose of this stu...
Autores principales: | Sanders, Donald B., Rosenfeld, Jeffrey, Dimachkie, Mazen M., Meng, Lisa, Malik, Fady I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404445/ https://www.ncbi.nlm.nih.gov/pubmed/25742919 http://dx.doi.org/10.1007/s13311-015-0345-y |
Ejemplares similares
-
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
por: Bril, Vera, et al.
Publicado: (2023) -
Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial
por: Pasnoor, Mamatha, et al.
Publicado: (2020) -
Tirasemtiv amplifies skeletal muscle response to nerve activation in humans
por: Hansen, Richard, et al.
Publicado: (2014) -
Discovery of Tirasemtiv, the First
Direct Fast Skeletal Muscle Troponin Activator
por: Collibee, Scott E., et al.
Publicado: (2018) -
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials
por: Guptill, Jeffrey T., et al.
Publicado: (2023)